BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 13, 2021
View Archived Issues
Equillium presents additional data from EQUALISE study of itolizumab
Read More
ON-108600 leads to potent tumor growth inhibition in chemotherapy-resistant TNBC models
Read More
Phase Ib/II data reported from CARTITUDE-1 study of ciltacabtagene autoleucel
Read More
Preclinical data confirm survival benefit of adding Veyonda to LuPSMA in prostate cancer
Read More
lncRNA HULC linked to phenylketonuria prevention, HULC-mimetics show therapeutic promise
Read More
B-Raf, MEK1 inhibitors discovered at Chugai
Read More
Shenzhen Salubris Pharmaceuticals presents new cathepsin K inhibitors
Read More
Shanghai Hengrui Pharmaceutical and others patent ADCs with eribulin derivatives
Read More
SSAO inhibitors identified at Shanghai Ennova Biopharmaceutical, Ennovabio Pharmaceuticals
Read More
VYNE and In4Derm enter licence agreement for discovery and development of BET inhibitor platform
Read More
FDA clears IND application for first-in-human trial of IO-108
Read More
Mustang Bio and Mayo Clinic collaborate on development of novel CAR T technology
Read More
Sen-Jam and Duke-NUS Medical School partner to develop novel COVID-19 therapy
Read More
Cogent initiates phase II study of CGT-9486 in systemic mastocytosis
Read More
Nimbus and Schrödinger extend drug discovery collaboration
Read More
Moderna initiates phase I/II study of mRNA-3705 in methylmalonic acidemia
Read More
Phase I/II study of ChulaCov19 vaccine initiates at Chulalongkorn University
Read More
SARS-CoV-2 spike ectodomain protein StriFK vaccine with adjuvant reduces transmission in animals
Read More
